Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Sestak

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialJohn F Forbes, Ivana Sestak, Anthony Howell, et al.
Lancet (London, England)|May 4, 2013
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataJack Cuzick, Ivana Sestak, Bernardo Bonanni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2013
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrenceMichael D Allen, Gareth J Thomas, Sarah Clark, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2017
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2John M S Bartlett, Ikhlaaq Ahmed, Meredith M Regan, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Lancet (London, England)|December 22, 2015
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trialJohn F Forbes, Ivana Sestak, Anthony Howell, et al.
Lancet (London, England)|May 4, 2013
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataJack Cuzick, Ivana Sestak, Bernardo Bonanni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2013
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrenceMichael D Allen, Gareth J Thomas, Sarah Clark, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2017
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2John M S Bartlett, Ikhlaaq Ahmed, Meredith M Regan, et al.
BMC Medical Genomics|August 23, 2015
Development and verification of the PAM50-based Prosigna breast cancer gene signature assayBrett Wallden, James Storhoff, Torsten Nielsen, et al.
Pageof 7